A variação de pluralidade nas estruturas predictaivas da variedade falada na região de São José do Rio Preto

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Analyse de la substitution entre combustibles dans le secteur residentiel en Haïti

Inclut la bibliographie

Motivações em competição na variação sociolinguística: o plural dos predicativos na variedade de São José do Rio Preto

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Desempenho de tractores florestais processadores

A time-and-motion study in wood processing of the Eucalyptus harvester's operational cycle was developed. The objective was to evaluate wood harvesters working under several site conditions. The research includes two kinds of harvesters while processing wood to supply paper and cellulose factories, as follows: a machine with twin tires and other one with large tracks, both connected to a different head harvester models. The forestry species were Eucalyptus saligna Smith and Eucalyptus grandis Hill ex Maiden, seven and eight years old, in slope terrains ranging from 0% to 10% degrees, under harvesting systems used by Votorantim and Suzano forestry companies, in São Paulo State, Brazi. Considering all field research, results disclosed that, for some conditions, both machines have shown mathematical correlation between some mechanical wood operation within the processing operational cycle and the saw logs production. All the mathematical correlations were found to express logarithmical models.

Indagine sociolinguistica sulla minoranza linguistica storica francese in Piemonte: il caso delle valli valdesi

Au Piémont quatre minorités linguistiques historiques sont protégées par la loi: occitane, française, provençale et walser. Les municipalités francophones du Piémont sont vingt-huit, dont la plupart se trouve sur un territoire appelé « vallées vaudoises ». Le français est parlé comme un dialecte régional et il peut être considéré comme une variété de la langue, car il diffère du français de France pour son vocabulaire et sa prononciation. Le but de cette étude est celui d’examiner le degré de diffusion du français dans les vallées vaudoises, vérifier la présence d’initiatives de protection et l’engagement de la population. La présente étude est composée par sept parties. Le Chapitre 1 et 2 présentent l’état des recherches et définissent la méthode et le but de l’étude. Le Chapitre 3 présente un aperçu de l’histoire linguistique de la région, examine la situation linguistique actuelle notamment des minorités linguistiques historiques et du dialecte régional et analyse les lois qui protègent les minorités. Le Chapitre 4 décrit le territoire habité par la minorité française et présente un aperçu sur les événements historiques qui ont fait de ce territoire une communauté multilingue. Le Chapitre 5 analyse les compétences de la population, le degré de diffusion et les traits sociolinguistiques de la minorité. Le Chapitre 6 décrit les raisons de l’importance de la préservation du français dans les vallées vaudoises et présente un aperçu des initiatives de protection. La Conclusion présente les résultats et les possibles évolutions futures de l’étude. Afin d’atteindre l’objectif de l’étude, un sondage en ligne et plusieurs interviews ont été effectués ; ceux-ci ont permis d’obtenir des données ensuite analysées d’un point de vue statistique. En général, ce patrimoine est aujourd’hui très fragile ; cependant, un procès de revitalisation a commencé.

Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials

Pathological complete response (pCR) to neoadjuvant treatment correlates with outcome in breast cancer. We determined whether characteristics of neoadjuvant therapy are associated with pCR. We used multi-level models, which accounted for heterogeneity in pCR across trials and trial arms, to analyze individual patient data from 3332 women included in 7 German neoadjuvant trials with uniform protocols. PCR was associated with an increase in number of chemotherapy cycles (odds ratio [OR] 1.2 for every two additional cycles; P = 0.009), with higher cumulative anthracycline doses (OR 1.6; P = 0.002), higher cumulative taxane doses (OR 1.6; P = 0.009), and with capecitabine containing regimens (OR 1.62; P = 0.022). Association of pCR with increase in number of cycles appeared more pronounced in hormone receptor (HR)-positive tumors (OR 1.35) than in HR-negative tumors (OR 1.04; P for interaction = 0.046). Effect of anthracycline dose was particularly pronounced in HER2-negative tumors (OR 1.61), compared to HER2-positive tumors (OR 0.83; P for interaction = 0.14). Simultaneous trastuzumab treatment in HER2-positive tumors increased odds of pCR 3.2-fold (P < 0.001). No association of pCR and number of trastuzumab cycles was found (OR 1.20, P = 0.39). Dosing characteristics appear important for successful treatment of breast cancer. Longer treatment, higher cumulative doses of anthracyclines and taxanes, and the addition of capecitabine and trastuzumab are associated with better response. Tailoring according to breast cancer phenotype might be possible: longer treatment in HR-positive tumors, higher cumulative anthracycline doses for HER2-negative tumors, shorter treatment at higher cumulative doses for triple-negative tumors, and limited number of preoperative trastuzumab cycles in HER2-positive tumors.

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

Background Idiopathic pulmonary fibrosis is a progressive and fatal lung disease with inevitable loss of lung function. The CAPACITY programme (studies 004 and 006) was designed to confirm the results of a phase 2 study that suggested that pirfenidone, a novel antifibrotic and anti-inflammatory drug, reduces deterioration in lung function in patients with idiopathic pulmonary fibrosis. Methods In two concurrent trials (004 and 006), patients (aged 40–80 years) with idiopathic pulmonary fibrosis were randomly assigned to oral pirfenidone or placebo for a minimum of 72 weeks in 110 centres in Australia, Europe, and North America. In study 004, patients were assigned in a 2:1:2 ratio to pirfenidone 2403 mg/day, pirfenidone 1197 mg/day, or placebo; in study 006, patients were assigned in a 1:1 ratio to pirfenidone 2403 mg/day or placebo. The randomisation code (permuted block design) was computer generated and stratified by region. All study personnel were masked to treatment group assignment until after final database lock. Treatments were administered orally, 801 mg or 399 mg three times a day. The primary endpoint was change in percentage predicted forced vital capacity (FVC) at week 72. Analysis was by intention to treat. The studies are registered with ClinicalTrials.gov, numbers NCT00287729 and NCT00287716. Findings In study 004, 174 of 435 patients were assigned to pirfenidone 2403 mg/day, 87 to pirfenidone 1197 mg/day, and 174 to placebo. In study 006, 171 of 344 patients were assigned to pirfenidone 2403 mg/day, and 173 to placebo. All patients in both studies were analysed. In study 004, pirfenidone reduced decline in FVC (p=0·001). Mean FVC change at week 72 was −8·0% (SD 16·5) in the pirfenidone 2403 mg/day group and −12·4% (18·5) in the placebo group (difference 4·4%, 95% CI 0·7 to 9·1); 35 (20%) of 174 versus 60 (35%) of 174 patients, respectively, had a decline of at least 10%. A significant treatment effect was noted at all timepoints from week 24 and in an analysis over all study timepoints (p=0·0007). Mean change in percentage FVC in the pirfenidone 1197 mg/day group was intermediate to that in the pirfenidone 2403 mg/day and placebo groups. In study 006, the difference between groups in FVC change at week 72 was not significant (p=0·501). Mean change in FVC at week 72 was −9·0% (SD 19·6) in the pirfenidone group and −9·6% (19·1) in the placebo group, and the difference between groups in predicted FVC change at week 72 was not significant (0·6%, −3·5 to 4·7); however, a consistent pirfenidone effect was apparent until week 48 (p=0·005) and in an analysis of all study timepoints (p=0·007). Patients in the pirfenidone 2403 mg/day group had higher incidences of nausea (125 [36%] of 345 vs 60 [17%] of 347), dyspepsia (66 [19%] vs 26 [7%]), vomiting (47 [14%] vs 15 [4%]), anorexia (37 [11%] vs 13 [4%]), photosensitivity (42 [12%] vs 6 [2%]), rash (111 [32%] vs 40 [12%]), and dizziness (63 [18%] vs 35 [10%]) than did those in the placebo group. Fewer overall deaths (19 [6%] vs 29 [8%]) and fewer deaths related to idiopathic pulmonary fibrosis (12 [3%] vs 25 [7%]) occurred in the pirfenidone 2403 mg/day groups than in the placebo groups. Interpretation The data show pirfenidone has a favourable benefit risk profile and represents an appropriate treatment option for patients with idiopathic pulmonary fibrosis.

The Integration of Formal and Non-formal Education: The Dutch “brede school”

The Dutch “brede school” (BS) development originates in the 1990s and has spread unevenly since: quicker in the primary than secondary educational sector. In 2007, there were about 1000 primary and 350 secondary BS schools and it is the intention of the government as well as the individual municipalities to extend that number and make the BS the dominant school form of the near future. In the primary sector, a BS cooperates with crèche and preschool facilities, besides possible other neighborhood partners. The main targets are, first, to enhance educational opportunities, particularly for children with little (western-) cultural capital, and secondly to increase women’s labor market participation by providing extra familial care for babies and small children. All primary schools are now obliged to provide such care. In the secondary sector, a BS is less neighborhood-orientated than a primary BS because those schools are bigger and more often located in different buildings. As in the primary sector, there are broad and more narrow BS, the first profile cooperating with many non-formal and other partners and facilities and the second with few. On the whole, there is a wide variety of BS schools, with different profiles and objectives, dependent on the needs and wishes of the initiators and the neighborhood. A BS is always the result of initiatives of the respective school and its partners: parents, other neighborhood associations, municipality etc. BS schools are not enforced by the government although the general trend will be that existing school organizations transform into BS. The integration of formal and non-formal education and learning is more advanced in primary than secondary schools. In secondary education, vocational as well as general, there is a clear dominance of formal education; the non-formal curriculum serves mainly two lines and objectives: first, provide attractive leisure activities and second provide compensatory courses and support for under-achievers who are often students with migrant background. In both sectors, primary and secondary, it is the formal school organization with its professionals which determines the character of a BS; there is no full integration of formal and non-formal education resulting in one non-disruptive learning trajectory, nor is there the intention to go in that direction. Non-formal pedagogues are partly professionals, like youth- and social workers, partly volunteers, like parents, partly non-educational partners, like school-police, psycho-medical help or commercial leisure providers. Besides that, the BS is regarded by government educational and social policy as a potential partner and anchor for community development. It is too early to make reliable statements about the effects of the BS movement in the Netherlands concerning the educational opportunities for disadvantaged children and their families, especially those with migrant background, and combat further segregation. Evaluation studies made so far are moderately positive but also point to problems of overly bureaucratized structures and layers, lack of sufficient financial resources and, again, are uncertain about long-term effects.

Lesiones estomatológicas del VPH genotipo 16 en la pre-adolescencia

El virus del Papiloma Humano infecta de manera selectiva al epitelio de la piel y las mucosas. Cuando se producen las infecciones, éstas pueden ser asintomáticas, provocando lesiones de tipos verrugosos o asociados a diversas neoplasias, benignos o malignos del tracto respiratorio superior y la cavidad bucal principalmente. Se presenta el caso de una niña con lesiones orales producidas por el VPH. Las lesiones se manifiestan clínicamente: elevadas, pediculadas y de superficie papilar; otras son planas y difusas sobre una base sésil.